IntegenX Thermo Fisher Scientific Acquires IntegenX Thermo Fisher said that IntegenX complements and enhances its existing human identification product portfolio. IntegenX Launches Next-Generation Rapid Forensic DNA Platform Premium The new platform is smaller and less expensive than the company's first-generation forensic DNA platform, processing a single DNA sample in around 70 minutes. Q&A: Peter Vallone of NIST Talks Trends in Rapid PCR for Forensics Premium Vallone recently authored a review of the field, noting that fully integrated rapid systems have special advantages. IntegenX Secures $10M Loan NEW YORK (GenomeWeb) – Human DNA identification firm IntegenX and Horizon Technology Finance said on Monday that IntegenX has secured a $10 million venture loan. IP Watch: IntegenX, Roche, Hologic, Life Tech, Others Win US Patents Premium The University of Massachusetts has been awarded Apr 29, 2014 Morpho to Market IntegenX's RapidHit System Mar 31, 2014 IntegenX Earns ISO 9001:2008 Certification Mar 27, 2014 Following Restructuring, New Sequencing-specific Products, WaferGen Eyes Top-Line Growth in 2014 Premium Mar 13, 2014 Applied Markets Watch: IntegenX RapidHIT Premium Feb 18, 2014 Life Tech, IntegenX Ink Distribution Deal for GlobalFiler Express Chemistry Jan 14, 2014 WaferGen Acquires IntegenX's NGS Library Prep Tech to Bolster Revenues, Complement Target Enrichment Premium Jan 9, 2014 People in the News: WaferGen Shuffles Board; Spinomix Names Nahas as CEO Premium Jan 7, 2014 Paired Ends: Robert Schueren, William McKenzie Premium Jan 7, 2014 WaferGen Buys NGS Sample Prep Assets from IntegenX Oct 23, 2013 IP Watch: Hologic, Life Tech, Chinese U of Hong Kong, U of Toledo, IntegenX Win US Patents Premium Sep 5, 2013 Applied Markets Watch: IntegenX RapidHit DNA Identification System Premium May 1, 2013 IP Watch: Sony Micronics, PATH, Life Tech, IntegenX, Samsung, Others Win US Patents Premium Apr 23, 2013 People in the News: Charles Dadswell, Christian Cabou, Susan Vogt, Martin Verhoef, Robert Schueren, and Others Premium Apr 18, 2013 People in the News: IntegenX Names Schueren as CEO; Applied BioCode Hires Aye as VP Premium Apr 4, 2013 Life Tech to Distribute LGC Forensic DNA Analysis System as Firms Eye Field-Based Testing Products Premium Mar 14, 2013 IP Watch: BioFire Diagnostics, SpeeDx, IntegenX, Life Technologies, Stanford Among US Patent Winners Premium Feb 28, 2013 Applied Markets Watch: IntegenX and SAIC Partner; InstantLabs Developing Horse Meat Test Premium Feb 21, 2013 Applied Markets Watch: Thermo Fisher, IntegenX, DuPont, and 3M Food Safety Premium Feb 19, 2013 IntegenX Inks Middle East Distribution Deal Nov 13, 2012 New Products: Roche's GS FLX+ Software; Agilent's SureSelect Human All-Exon Kits; More Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.